Related Experiment Video
Updated: Feb 6, 2026

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
Published on: August 25, 2022
Intraventricular CNS treatment with Colistin-Tigecycline combination: A case series
Vasiliki Tsolaki1, Marios Karvouniaris1, Efstratios Manoulakas1
1Intensive Care Unit, University Hospital of Larisa, University of Thessaly Medical School, Biopolis 41110, Greece.
Abstract:
"Healthcare-associated ventriculitis and meningitis" is a potentially devastating illness following neurosurgical procedures. Multidrug resistant (MDR) and extensively drug resistant (XDR) organisms such as Acinetobacter baumannii and Klebsiella pneumoniae have increasingly been isolated in ventriculitis and meningitis episodes. The treatment of these infections can be challenging, as the antimicrobial options are restricted. Regarding Central Nervous System (CNS) infections the transfer of the antibiotics to the Cerebrospinal Fluid (CSF) is often low which results in decreased drug levels at the infection site. The intraventricular (IVT) administration of antibiotics can be used as an adjunct to the intravenous (IV) treatment of Gram-negative MDR ventriculitis and meningitis, yet pertinent data is scarce. We present the successful management of three cases of healthcare-associated ventriculitis and meningitis due to XDR species with the combined intraventricular administration of colistin and off-label tigecycline, after the initial regimen of colistin given alone through both IVT and IV routes had failed.
Insights
Healthcare-associated ventriculitis and meningitis caused by extensively drug-resistant bacteria can be challenging to treat. Combining intraventricular colistin and tigecycline offers a promising treatment strategy when other methods fail.
Area of Science:
- Infectious Diseases
- Neurosurgery
- Pharmacology
Background:
- Healthcare-associated ventriculitis and meningitis are severe post-neurosurgical infections.
- Multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria, including Acinetobacter baumannii and Klebsiella pneumoniae, are increasingly implicated.
- Limited antimicrobial penetration into the cerebrospinal fluid (CSF) complicates treatment.
Observation:
- Three cases of XDR ventriculitis/meningitis were treated.
- Initial treatment with intravenous (IV) and intraventricular (IVT) colistin alone failed.
- A combination of IVT colistin and off-label IVT tigecycline was administered.
Findings:
- Successful management of XDR ventriculitis and meningitis was achieved.
- The combined IVT colistin and tigecycline regimen proved effective.
- This approach addressed treatment failure with monotherapy.
Implications:
- Intraventricular colistin and tigecycline combination therapy is a viable option for refractory Gram-negative CNS infections.
- This strategy may overcome antimicrobial resistance challenges in neurosurgical patients.
- Further research is warranted to establish optimal protocols for this combination therapy.
Related Concept Videos
Resistors In Series
In a series circuit, the...
Series Resonance
CNS Depressants: Alcohol and Nicotine
CNS Depressants: Barbiturates and Benzodiazepines
CNS Stimulants: Psychedelic Agents
Series and Parallel Capacitors
First, consider capacitors connected in series to a battery. In this configuration, the plate connected to the battery's positive terminal develops a positive charge, while the plate attached to the negative terminal becomes negatively charged. An equal magnitude of charge is induced on the...

